R&D Partner Content 6th Treg Directed Therapies Summit Get ready for the much-anticipated return of the 6th Treg-Directed Therapies Summit! This year promises an enhanced experience wi
R&D Partner Content 4th Gene Therapy for Muscular Disorders 2024 4th Gene Therapy for Muscular Disorders Summit (April 16-18, Boston)
R&D Partner Content 5th RNA Editing Summit 2024 Pioneering RNA Editing Drugs Towards Clinical Realities
R&D Partner Content Obesity & Weight Loss Drug Development Summit Next Generation of GLP & Weight Loss Therapies
R&D Partner Content 3rd World ADC Asia Optimising Physiochemical, Potency & Impurity Analytical Methods to Ensure Regulatory Compliance
R&D Partner Content 3rd ADC Analytical Development Summit The 3rd ADC Analytical Development Summit is your only industry-dedicated meeting providing you with the key insights to ensure y
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.